Metronidazolo Same Savoma Medicinali (Metronidazole)

Metronidazole penetrates anaerobic bacterial cells and is reduced to reactive nitro radicals that damage DNA and inhibit nucleic acid synthesis, leading to bacterial death. In addition, it exerts anti‑inflammatory effects by modulating cytokine release and neutrophil activity, which contributes to improvement of inflammatory skin disorders.

The appropriate dose and frequency of Metronidazolo Same Savoma are determined by the prescribing healthcare professional based on the specific condition, severity, patient age, and other clinical factors. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety data for topical metronidazole in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with other topical antibiotics such as clindamycin or erythromycin, metronidazole offers both antibacterial and anti‑inflammatory actions, making it particularly useful for rosacea and acne where inflammation is prominent. Its spectrum is focused on anaerobic organisms, and it generally has a favorable tolerability profile, though individual response may vary.

Metronidazolo Same Savoma should be stored below 25 °C in its original packaging, protected from moisture and direct light. Keep the container tightly closed when not in use and avoid exposing the product to excessive heat or humidity to maintain its stability.

The product is applied topically to the affected skin area, typically once or twice daily as directed by the prescriber. A thin layer should be spread gently and allowed to dry before covering the area with clothing or bandages, unless otherwise instructed.

Serious adverse reactions, although rare, include severe allergic responses such as rash, swelling, or hives, and potentially life‑threatening conditions like Stevens‑Johnson syndrome. Neurological symptoms such as peripheral neuropathy or seizures also warrant immediate medical attention.

Individuals with a known hypersensitivity to metronidazole or any component of the formulation should avoid using the product. It is also contraindicated on severely damaged or open wounds, and caution is advised in patients with significant liver disease or those taking interacting medications without medical supervision.